New nanoparticle can help detect cancer at early stages

01/23/2008 | Examiner (Washington, D.C.), The

Researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine have developed nanoparticles that help preserve biomarkers, which can indicate cancer and other diseases, a step that could lead to cancer detection at much earlier stages. Different biomarkers can be tested by altering the nanoparticles.

View Full Article in:

Examiner (Washington, D.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations